RadNet CoL Researcher Dr Miguel Reis Ferreira and Dr Teresa Guerrero Urbano along with King’s College London Researcher Dr Anjali Chander have found that a bacteria is toxic for head and neck cancer and may lead to better outcomes for patients. Fusobacterium is usually associated with the progression of bowel cancer. However, new research published in Cancer Communications shows that in the most common type of head and neck cancer, Fusobacterium, does the opposite – the bacteria destroys tumour cells and could act as a biomarker for how patients will react to treatment.
For more details read the paper here and the press release on the Guy’s and St Thomas’s website.
